Aug 10, 2026
AbCellera (ABCL) Stock Surges 32% on Positive Menopause Treatment Results
AbCellera (ABCL) stock soared 32% after its menopause treatment ABCL635 achieved Phase 2 trial goals, reducing hot flashes without serious side effects.
The post AbCellera (ABCL) Stock Surges 32% on Positive Menopause Treatment Results appeared first on Blockonomi.
Source: Blockonomi →Related News
- 56 minutes ago
ARK Invest Exits AMD (AMD) Position, Reallocates to Broadcom and Cerebras
- 1 hour ago
PayPal (PYPL) Plunges 13% After Stripe-Advent Consortium Abandons Takeover Bid
- 1 hour ago
Rubrik (RBRK) Stock Drops 8% Despite Strong Q2 Earnings Beat and Raised Guidance
- 1 hour ago
Autodesk (ADSK) Stock Slides 4% After Fiscal 2027 Earnings Outlook Disappoints
- 1 hour ago
Broadcom (AVGO) Stock: Should You Buy Ahead of Wednesday’s Earnings Report?